B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520)

PRESS RELEASE

published on 10/31/2024 at 19:11, 1 year 4 months ago

EQS-Adhoc: BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties
BRAIN Biotech AG signs exclusive pharma licensing agreement with Akribion Therapeutics GmbH for G-dase E® CRISPR-Cas technology, potentially receiving up to EUR 92.3 million milestone fees and royalties

BRAIN Biotech AG CRISPR-Cas Technology Pharma Licensing Agreement Akribion Therapeutics GmbH G-dase E®
BRIEF

published on 10/03/2024 at 14:05, 1 year 5 months ago

Prof. Dr. Wiltrud Treffenfeldt Steps Down from BRAIN Biotech AG Supervisory Board

Biotechnology Resignation Supervisory Board BRAIN Biotech AG Wiltrud Treffenfeldt
BRIEF

published on 10/03/2024 at 14:05, 1 year 5 months ago

Le professeur Wiltrud Treffenfeldt quitte le conseil de surveillance de BRAIN Biotech AG

Biotechnologie Démission Conseil De Surveillance BRAIN Biotech SA Wiltrud Treffenfeldt
PRESS RELEASE

published on 10/03/2024 at 14:00, 1 year 5 months ago

Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Prof. Dr. Wiltrud Treffenfeldt resigns from Supervisory Board of BRAIN Biotech AG for personal reasons. Search for successor initiated. Company specializes in industrial biotechnology solutions

Biotechnology Resignation Supervisory Board Successor BRAIN Biotech AG
BRIEF

published on 09/20/2024 at 19:55, 1 year 6 months ago

BRAIN Biotech AG Secures EUR 128.88 Million Deal with Royalty Pharma

Non-dilutive Financing BRAIN Biotech AG Royalty Monetization Investigational Compound Industrial Enzymes
BRIEF

published on 09/20/2024 at 19:55, 1 year 6 months ago

BRAIN Biotech AG conclut un accord de 128,88 millions d'euros avec Royalty Pharma

BRAIN Biotech SA Financement Non Dilutif Monétisation Des Redevances Composé Expérimental Enzymes Industrielles
BRIEF

published on 09/20/2024 at 19:52, 1 year 6 months ago

BRAIN Biotech AG Secures Royalty Monetization Deal Worth Up to EUR 128.88 Million

BRAIN Biotech Royalty Monetization Deucrictibant Royalty Pharma Hereditary Angioedema
BRIEF

published on 09/20/2024 at 19:52, 1 year 6 months ago

BRAIN Biotech AG conclut un accord de monétisation de redevances d'une valeur maximale de 128,88 millions d'euros

CERVEAU Biotechnologie Royalty Pharma Monétisation Des Redevances Déucritibant Œdème De Quincke Héréditaire
PRESS RELEASE

published on 09/20/2024 at 19:50, 1 year 6 months ago

BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
BRAIN Biotech AG concludes a major pharma compound transaction valued up to EUR 128.88 million, monetizing royalty rights with Royalty Pharma for investigational compound deucrictibant from BioIncubator

BRAIN Biotech AG Pharma Royalty Pharma Compound Transaction BioIncubator
PRESS RELEASE

published on 09/20/2024 at 19:47, 1 year 6 months ago

EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma
BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma

BRAIN Biotech AG Deucrictibant Royalty Pharma Royalty Monetization Deal EUR 128.88 Million

Published on 03/20/2026 at 23:00, 1 day 10 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 11 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 12 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 1 day 19 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 20 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/20/2026 at 22:45, 1 day 10 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 12 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 12 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 12 hours ago

BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 13 hours ago

INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action

View all EQS

Published on 03/20/2026 at 19:00, 1 day 14 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 14 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 15 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 15 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 1 day 15 hours ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News